MMP12 and lung carcinoma: Building on a previous study on recently validated MMP12 inhibitors [40], this study aims to characterize the anticancer potential of selected MMP12 inhibitor candidates, identify associated genomic biomarkers, and define the mechanistic consequences of MMP12 suppression in lung cancer.